Results 191 to 200 of about 3,285 (240)
Pearson syndrome and mitochondrial encephalomyopathy in a patient with a deletion of mtDNA.
M A McShane +6 more
openalex
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Mitochondrial Encephalomyopathies
Neurologic Clinics, 1988Mitochondrial encephalomyopathies are neurodegenerative disorders characterized by ragged-red myopathy and encephalopathy, which are recognized with increasing frequency. This article presents the clinical features; pertinent historical, biochemical, and genetic aspects; evaluation; and treatment of mitochondrial encephalomyopathies of childhood and ...
P L, Peterson, M E, Martens, C P, Lee
openaire +4 more sources
Mitochondrial encephalomyopathies: therapeutic approaches
Neurological Sciences, 2000Therapy of mitochondrial encephalomyopathies (defined restrictively as defects of the mitochondrial respiratory chain) is woefully inadequate, despite great progress in our understanding of the molecular bases of these disorders. We review available and experimental therapeutic approaches, which fall into seven categories: (1) palliative therapy; (2 ...
S, DiMauro, M, Hirano, E A, Schon
openaire +4 more sources
Mitochondrial Encephalomyopathies
Neurologic Clinics, 1990The mitochondrial diseases present with great heterogeneity. They are often multisystemic and vary considerably in age at onset, distribution of weakness, severity, and course. Only nonthyroidal hypermetabolism has a distinctive clinical presentation. Therefore, attempts at classification have generated some controversy.
S, DiMauro +5 more
+9 more sources
Mitochondrial Encephalomyopathies
Archives of Neurology, 1993Mitochondrial diseases are uniquely interesting from a genetic point of view because mitochondria contain their own DNA (mtDNA) and are capable of synthesizing a small but vital set of proteins, all of which are components of respiratory chain complexes.
S, DiMauro, C T, Moraes
+6 more sources
Mitochondrial encephalomyopathy
2023Mitochondrial dysfunction, especially perturbation of oxidative phosphorylation and adenosine triphosphate (ATP) generation, disrupts cellular homeostasis and is a surprisingly frequent cause of central and peripheral nervous system pathology. Mitochondrial disease is an umbrella term that encompasses a host of clinical syndromes and features caused by
Ng YS, McFarland R
openaire +3 more sources
Mitochondrial Encephalomyopathies
Annals of the New York Academy of Sciences, 2004Abstract: Therapy for mitochondrial diseases is woefully inadequate. How‐ever, lack of cure does not equate with lack of treatment. In this review, we consider sequentially several different therapeutic approaches. Palliative therapy is dictated by good medical practice and includes anticonvulsant medication, control of endocrine dysfunction, and ...
DiMauro S., Mancuso M., Naini A.
openaire +4 more sources
Mitochondrial Encephalomyopathies☆
2009Increasingly numerous studies are being devoted to mitochondrial diseases, notably those which involve the neuromuscular system. Our knowledge and understanding of these diseases is progressing rapidly. We owe to Luft et al. (1962) the first description of this type of diseases.
A, Lombes, E, Bonilla, S, Dimauro
openaire +2 more sources
Mitochondrial encephalomyopathy
Neuropathology, 2000Mitochondrial encephalomyopathy is a disease based on multisystemic mitochondrial dysfunction. Pathologic, biochemical and molecular genetic approaches to the disease have revealed the complex features of the phenotype and its relationship to the genotype.
openaire +4 more sources

